» Articles » PMID: 8818183

HLA Risk Haplotype Cw6,DR7,DQA1*0201 and HLA-Cw6 with Reference to the Clinical Picture of Psoriasis Vulgaris

Overview
Specialty Dermatology
Date 1996 Jun 1
PMID 8818183
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Psoriasis vulgaris has HLA associations. We have previously defined HLA-Cw6,DR7,DQA1*0201 as the central element of the risk haplotypes for psoriasis. On the other hand, Cw6 as a single gene has the strongest association with psoriasis. The aim of this study was to determine whether the risk haplotype and Cw6 correlate with the clinical parameters of the disease. The series consisted of 64 patients and the clinical parameters were age at onset, family history of psoriasis, arthritis and the frequency of inpatient treatment. The HLA risk haplotype Cw6,DR7,DQA1*0201 had previously been found in 30% and Cw6 alone in 54% of the patients. The presence of Cw6 correlated with early age at onset (Pc = 0.01). The presence of the risk haplotype correlated with a positive family history of psoriasis among the first-degree relatives (Pc = 0.02) and an overall positive family history (Pc = 0.04), but Cw6 had a stronger correlation with an overall positive family history (Pc = 0.01). There were no positive correlations with arthritis or the number of inpatient treatment periods. Only type I psoriasis was associated with Cw6 (Pc = 0.0006). In conclusion, Cw6 and the haplotype Cw6,DR7,DQA1*0201 are important in the heredity of psoriasis vulgaris, but the presence of Cw6 alone is sufficient to indicate a clinically significant risk for psoriasis.

Citing Articles

HLA-C Genotyping Reveals Haplotype C*07 as a Potential Biomarker of Late Psoriasis Onset in Moroccan Patients.

Benlabsir C, Riyad M, Saik I, Ettayebi H, Aazzane O, Nassar K Curr Issues Mol Biol. 2023; 45(2):1012-1023.

PMID: 36826011 PMC: 9955500. DOI: 10.3390/cimb45020066.


Prevalence of Atherosclerosis in Psoriatic Patients Detected with Epiaortic Color Doppler Ultrasound and Computed Tomography Angiography.

Dattola A, Manenti G, Ferrari D, Vollono L, Marsico S, Lamacchia F Dermatol Pract Concept. 2022; 12(1):e2022011.

PMID: 35223156 PMC: 8824295. DOI: 10.5826/dpc.1201a11.


Association of HLA Alleles and HLA Haplotypes with Psoriasis, Psoriatic Arthritis and Disease Severity in a Miscegenated Population.

Cassia F, Cardoso J, Porto L, Ramos-E-Silva M, Carneiro S Psoriasis (Auckl). 2021; 11:41-51.

PMID: 34007822 PMC: 8121669. DOI: 10.2147/PTT.S258050.


Clinical Features and Genetic Polymorphism in Chinese Patients with Erythrodermic Psoriasis in a Single Dermatologic Clinic.

Lo Y, Chiu H, Tsai T Mol Diagn Ther. 2019; 24(1):85-93.

PMID: 31820331 DOI: 10.1007/s40291-019-00441-x.


and are strongly associated with the risk of psoriasis in the population of northern Poland.

Stawczyk-Macieja M, Szczerkowska-Dobosz A, Rebala K, Gabig-Ciminska M, Nowicki R, Haras A Postepy Dermatol Alergol. 2018; 35(3):286-292.

PMID: 30008647 PMC: 6041718. DOI: 10.5114/ada.2018.76226.


References
1.
Karvonen J, TILIKAINEN A, Lassus A . HLA antigens in psoriasis. A family study. Ann Clin Res. 1976; 8(5):298-304. View

2.
Karvonen J . HL-A antigens in psoriasis with special reference to the clinical type, age of onset, exacerbations after respiratory infections and occurrence of arthritis. Ann Clin Res. 1975; 7(5):301-11. View

3.
Elder J, Henseler T, Christophers E, Voorhees J, Nair R . Of genes and antigens: the inheritance of psoriasis. J Invest Dermatol. 1994; 103(5 Suppl):150S-153S. DOI: 10.1111/1523-1747.ep12399486. View

4.
Farber E, NALL M . The natural history of psoriasis in 5,600 patients. Dermatologica. 1974; 148(1):1-18. DOI: 10.1159/000251595. View

5.
Henseler T, Christophers E . Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985; 13(3):450-6. DOI: 10.1016/s0190-9622(85)70188-0. View